Last updated on May 2020

A Study of Parsaclisib in Primary Sj gren's Syndrome


Brief description of study

The purpose of this study is to assess the impact of parsaclisib on the signs and symptoms of Sjgren's syndrome (SS).

Clinical Study Identifier: NCT03627065

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.